Apollo Health Ventures logo

Apollo Health Ventures

Europe, Hamburg, Germany, Hamburg

Description

Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.

Investor Profile

Apollo Health Ventures has made 16 investments, with 3 in the past 12 months and 38% as lead.

Stage Focus

  • Seed (69%)
  • Series A (25%)
  • Series B (6%)

Country Focus

  • United States (50%)
  • Switzerland (19%)
  • The Netherlands (13%)
  • Germany (13%)
  • United Kingdom (6%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Life Science
  • Product Research
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Apollo Health Ventures frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 2
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 2
Evotec
Europe, Hamburg, Germany, Hamburg
Co-Investments: 2
BrightEdge Fund
North America, Georgia, United States, Atlanta
Co-Investments: 2
4See Ventures
Europe, Geneve, Switzerland, Secheron
Co-Investments: 3
BB
Europe, Zug, Switzerland, Zug
Co-Investments: 3
Broadview Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
AB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Schroder Adveq
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3

Which angels does Apollo Health Ventures often collaborate with?

BB
North America, California, United States
Shared Deals: 1
KW
North America, California, United States, San Francisco
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by Apollo Health Ventures?

Auron Therapeutics

Newton, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series BFeb 4, 2025
Amount Raised: $27,000,000
Refoxy Pharma

Berlin, Berlin, Germany

Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.

ManufacturingPharmaceuticalTherapeutics
SeedDec 4, 2024
Amount Raised: $9,566,159
Booster Therapeutics

Berlin, Berlin, Germany

Booster Therapeutics is a biotech company that offers regulation of cellular homeostasis, as well as develops medicines for aging diseases.

BiotechnologyProduct ResearchTherapeutics
SeedOct 10, 2024
Amount Raised: $15,000,000
Aeovian Pharmaceuticals

San Francisco, California, United States

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AMar 28, 2024
Amount Raised: $50,000,000
Cleara Biotech

Utrecht, Utrecht, The Netherlands

Cleara is developing therapeutics to eliminate senescent cells.

Biotechnology
SeedSep 28, 2022
Amount Raised: $2,500,000
Auron Therapeutics

Wellesley, Massachusetts, United States

Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.

BiotechnologyHealth CareTherapeutics
Series AJul 20, 2022
Amount Raised: $48,000,000
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedFeb 9, 2022
Amount Raised: $5,000,000
Bloom Science

San Diego, California, United States

Bloom Science is a clinical-stage central nervous system company developing novel therapeutics for patients with neurological disorders.

BiopharmaBiotechnologyMedical
Series ADec 9, 2021
Amount Raised: $12,000,000
Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedJun 16, 2021
Amount Raised: $9,600,000
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedMay 20, 2021
Amount Raised: $20,053,856